Is Netflix Stock Still a Buy After Earnings, Price Hikes?
Analysts were bullish on Netflix stock ahead of its earnings beat, but what is Wall Street saying now? We take a closer look.
Evolent Health price target lowered to $20 from $29 at BTIG
BTIG lowered the firm’s price target on Evolent Health (EVH) to $20 from $29 but keeps a Buy rating on the shares. The firm notes it was ...
Visteon price target lowered to $115 from $140 at Barclays
Barclays lowered the firm’s price target on Visteon (VC) to $115 from $140 and keeps an Overweight rating on the shares as part of a Q4 ...
These Analysts See ‘New Age Opportunities’ Pushing Tesla Stock Toward $500
Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...
Needham cuts Nlight stock target, maintains Buy as Defense segment faces short-term headwinds
Needham analysts have revised the price target for Nlight (NASDAQ:LASR) shares, reducing it to $14.00 from the previous $16.00, while still maintaining a Buy rating on the company. According to ...
Xcel Energy stock target cut, keeps buy rating on positive outlook
Jefferies demonstrated continued confidence in Xcel Energy (NASDAQ:XEL) shares despite a slight decrease in the company's price target, which was adjusted from $76.00 to $75.00. The firm maintained ...